Hematopoietic/Lymphoid Cancer Active Not Recruiting Phase 3 Trials for Olanzapine (DB00334)

IndicationStatusPhase
DBCOND0030132 (Hematopoietic/Lymphoid Cancer)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02116530Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic ChemotherapySupportive Care